Create
Query
event_store.db
—
signals
actions
approvals
artifacts
commitments
constraints
conversation_compaction
conversation_state
conversation_turns
dead_letters
decisions
deliveries
effects
email_messages
email_reply_drafts
email_threads
entities
entity_aliases
entity_tags
episode_context_index
episodes
event_subjects
events
events_archive
fact_sources
facts
inbox_items
inbox_links
jobs
leader_leases
links
memory_candidates
memory_embeddings
memory_items
memory_items_fts
(v)
memory_items_fts_config
memory_items_fts_data
memory_items_fts_idx
opportunity_memory
pending_interactions
proposal_sources
proposals
reminders
schedules
schema_migrations
signal_candidates
signal_fps
signals
sms_conversations
sms_messages
sms_reply_drafts
source_cursors
sources
sqlite_sequence
sqlite_stat1
stream_cursors
threads
watchers
Toggle helper tables
memory_items_fts_content
memory_items_fts_docsize
memory_items_fts_segdir
memory_items_fts_segments
memory_items_fts_stat
Structure
Content
Query
Insert
Drop
Import
Export
Update row sig_2ac2cc9418be in signals
id
sig_2ac2cc9418be
Primary key.
TEXT
event_id
12937
TEXT NOT NULL
watcher_id
NULL
TEXT
signal_type
discovery_ipo_delta
TEXT NOT NULL
value
{"aggregator_url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQVzlHcllLZVB6UkxkZldiQjgzMjF0TkduRG5BMzlBd0Rjd3MxRl83cHhzMW4wVXJMS3hiUWV3RFJSVm40T09rUnA3ODlodFJKQy1GbzFQQ2VobWFYSHBJZUZWb09vWG9Qd2h5dWVUSDdhakdMVFVBbGZvd05DUkVuWlFKMHMzVk0?oc=5","as_of":"2026-04-09T16:35:58.987693+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQVzlHcllLZVB6UkxkZldiQjgzMjF0TkduRG5BMzlBd0Rjd3MxRl83cHhzMW4wVXJMS3hiUWV3RFJSVm40T09rUnA3ODlodFJKQy1GbzFQQ2VobWFYSHBJZUZWb09vWG9Qd2h5dWVUSDdhakdMVFVBbGZvd05DUkVuWlFKMHMzVk0?oc=5","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_6ed82cc3b531efb1","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-10T02:26:48.130910+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQVzlHcllLZVB6UkxkZldiQjgzMjF0TkduRG5BMzlBd0Rjd3MxRl83cHhzMW4wVXJMS3hiUWV3RFJSVm40T09rUnA3ODlodFJKQy1GbzFQQ2VobWFYSHBJZUZWb09vWG9Qd2h5dWVUSDdhakdMVFVBbGZvd05DUkVuWlFKMHMzVk0?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"gstatic.com","publisher_resolution":"canonical_aggregator_unresolved","requested_url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQVzlHcllLZVB6UkxkZldiQjgzMjF0TkduRG5BMzlBd0Rjd3MxRl83cHhzMW4wVXJMS3hiUWV3RFJSVm40T09rUnA3ODlodFJKQy1GbzFQQ2VobWFYSHBJZUZWb09vWG9Qd2h5dWVUSDdhakdMVFVBbGZvd05DUkVuWlFKMHMzVk0?oc=5","source_event_id":"evt_fcbceeccd6fa","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"63b4632b15e65022","kind":"ipo_calendar","published_at":"2026-04-09T16:11:00+00:00","publisher_domain":"gstatic.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.62,"dates_mentioned":[],"entities":[{"asset_class":"equity (IPO filing)","name":"Avalyn Pharma","relevance":"high","symbol":"","type":"company"}],"event_type":"listing","information_gaps":["No IPO filing date is provided in the provided text.","No details are provided on the IPO structure (e.g., exchange, ticker, offering size, underwriters).","No details are provided on the timing or terms of the $100M funding round.","The provided article text appears to contain only page styling/HTML fragments, not the actual article content; only the headline/summary were available."],"key_facts":["The Business Journals reports that Boston biotech Avalyn Pharma filed to go public.","The report states this IPO filing followed a $100M funding round."],"numeric_claims":[{"label":"Funding round size","value":"$100M"}],"primary_claim":"Avalyn Pharma filed to go public after completing a $100M funding round.","relevance_score":0.72,"sentiment":"neutral","source_quality":"high","summary":"Boston biotech Avalyn Pharma has filed to go public following a $100M funding round, according to The Business Journals.","topics":["IPO filing","biotech","funding round","Boston","The Business Journals"]},"source":"The Business Journals","source_domain":"gstatic.com","summary":"Boston biotech Avalyn Pharma files to go public after $100M funding round The Business Journals","tickers":[],"title":"Boston biotech Avalyn Pharma files to go public after $100M funding round - The Business Journals","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp"}
TEXT NOT NULL
threshold
NULL
TEXT
direction
NULL
TEXT
severity
NULL
TEXT
window
NULL
TEXT
source
discovery_ingestor
TEXT NOT NULL
reason_trace
{"_evidence_event_ids":["evt_fcbceeccd6fa"]}
TEXT
dedupe_key
signal_enriched:discovery_ipo_delta:0dd8ece4fc4042b8
TEXT NOT NULL
throttle_s
INTEGER (default 0
created_at
2026-04-09T16:35:58.987693+00:00
TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')
Update
Cancel